Genomic duplications in anophthalmia, microphthalmia and coloboma
无眼症、小眼症和缺损的基因组重复
基本信息
- 批准号:10538727
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:3q29Advanced DevelopmentAffectAnimal ModelAnophthalmosBCL2L1 geneBilateralCollectionColobomaComplexCopy Number PolymorphismDLG1 geneDNADataDetectionDevelopmentDiseaseDissectionEnrollmentExhibitsEyeEye DevelopmentFamilyFutureGenesGenetic studyGenomic SegmentGenomicsHealthHumanIndividualInheritedLiteratureLive BirthMicrophthalmosModelingOrthologous GenePathway interactionsPatientsPenetrancePhenotypeRecurrenceReportingRoleSamplingStructureSyndromeTestingTimeVariantZebrafishbasecohortde novo mutationdefined contributiondosagegenetic disorder diagnosishuman diseasenovelprobandsuccess
项目摘要
PROJECT SUMMARY
Microphthalmia, anophthalmia and coloboma (MAC) is a group of severe ocular phenotypes characterized by a
reduction in size or absence of the eye or a gap (hole) involving various ocular structures. The success rate for
identifying a genetic diagnosis for MAC spectrum remains incomplete, making the discovery of novel
mechanisms an important priority. Copy number variations (CNVs) are deletions or duplications of genomic
segments that can be inherited or occur as dominant de novo variants. There is a growing list of developmental
phenotypes associated with CNVs, indicating that dosage imbalance represents an important factor in human
disease. Within this group, the contribution of dosage gain variants remains underappreciated due to many
factors including the involvement of multiple genes necessitating complex functional studies. In this proposal,
we will combine our expertise in MAC and the zebrafish model to reveal novel mechanisms of these
debilitating human phenotypes. We present evidence for the association of dosage gain at two different
genomic regions, 20q11 and 3q29, with isolated and syndromic MAC, with multiple affected families identified
in our cohort for both loci. We will utilize our extensive collection of DNA samples from individuals affected with
MAC to further define the contribution of these and other candidate regions to human disease, as well as to
discover novel disease-causing dosage-sensitive loci. Specifically, we will: 1) identify the driver gene(s) and
pathway(s) involved in phenotypes associated with 20q11 dosage variation by generating and studying dosage
gain/loss models for the zebrafish id1, bcl2l1 and tpx2 genes, identified as top candidates within the region; 2)
reveal driver gene(s) and pathway(s) involved in phenotypes associated with 3q29 dosage variation by
exploring dosage gain/loss models for zebrafish rubcn, dlg1 and/or bdh1 genes, located in the affected human
region; and 3) uncover critical dosage-sensitive regions involved in human MAC spectrum by additional
mapping of previously identified CNVs as well as exploring a large cohort (760 samples from affected
individuals and their relatives) of extensively tested but unexplained MAC families, followed by dissection of
novel candidate regions in zebrafish. The successful completion of this project will identify novel factors in
human ocular development, both genomic regions/genes and affected pathways, and generate robust animal
models of these complex human phenotypes.
项目摘要
微观恐惧症,性心含量和古罗巴马(MAC)是一组以A为特征的严重眼表型
减少涉及各种眼部结构的眼睛的大小或缺失或间隙(孔)。成功率
确定MAC光谱的遗传诊断仍然不完整,从而发现新颖
机制是重要的优先级。拷贝数变化(CNV)是基因组的缺失或重复
可以继承或作为主要de从头变体而出现的段。发育越来越多的清单
与CNV相关的表型,表明剂量不平衡是人类的重要因素
疾病。在该组中,由于许多
包括需要复杂功能研究的多个基因参与的因素。在此提案中,
我们将在Mac和斑马鱼模型中结合我们的专业知识,以揭示这些新型机制
使人类表型衰弱。我们提供了两个不同的剂量增益关联的证据
基因组区域,20q11和3Q29,具有孤立和综合症的MAC,并确定了多个受影响的家族
在我们的两个基因座的队列中。我们将利用受影响的个体的大量DNA样品集
Mac进一步定义了这些和其他候选地区对人类疾病的贡献,以及
发现新型致病剂量敏感的基因座。具体来说,我们将:1)确定驱动器基因和
通过产生和研究剂量,参与与20q11剂量变化相关的表型的途径
斑马鱼ID1,BCL2L1和TPX2基因的增益/损失模型,被确定为该地区的顶级候选者; 2)
揭示了与3q29剂量变化相关的表型的驱动基因和途径
探索位于受影响人类
地区; 3)通过额外
先前识别的CNV和探索大型队列的映射(760个样本
经过广泛测试但无法解释的MAC家庭的个人及其亲戚,然后解剖
斑马鱼的新型候选地区。该项目的成功完成将确定新的因素
人眼发育,基因组区域/基因和影响途径,并产生健壮的动物
这些复杂的人类表型的模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elena V Semina其他文献
Elena V Semina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elena V Semina', 18)}}的其他基金
Exploring a new model to study developmental eye diseases
探索研究发育性眼病的新模型
- 批准号:
10678123 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Genomic duplications in anophthalmia, microphthalmia and coloboma
无眼症、小眼症和缺损的基因组重复
- 批准号:
10680543 - 财政年份:2022
- 资助金额:
$ 38万 - 项目类别:
WDR37: a novel factor in human congenital multisystem disease
WDR37:人类先天性多系统疾病的新因素
- 批准号:
9980441 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
WDR37: a novel factor in human congenital multisystem disease
WDR37:人类先天性多系统疾病的新因素
- 批准号:
9814234 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
MAB21L Family in Human Ocular Disease and Development
MAB21L 家族在人类眼部疾病和发育中的作用
- 批准号:
9424669 - 财政年份:2017
- 资助金额:
$ 38万 - 项目类别:
MAB21L Family in Human Ocular Disease and Development
MAB21L 家族在人类眼部疾病和发育中的作用
- 批准号:
9247511 - 财政年份:2017
- 资助金额:
$ 38万 - 项目类别:
Identification of new mechanisms for human congenital disorders
识别人类先天性疾病的新机制
- 批准号:
8033773 - 财政年份:2010
- 资助金额:
$ 38万 - 项目类别:
Identification of new mechanisms for human congenital disorders
识别人类先天性疾病的新机制
- 批准号:
7873943 - 财政年份:2010
- 资助金额:
$ 38万 - 项目类别:
相似国自然基金
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:32100463
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
- 批准号:21922410
- 批准年份:2019
- 资助金额:120 万元
- 项目类别:优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
- 批准号:81402157
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Examining the multilevel factors on quality of end-of-life care among cancer patients in Puerto Rico
检查影响波多黎各癌症患者临终关怀质量的多层次因素
- 批准号:
10557584 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
A Novel Sublingual Vaccine to Prevent Neisseria Gonorrhoeae Infection
预防淋病奈瑟菌感染的新型舌下疫苗
- 批准号:
10699065 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Understand and mitigating the influence of extreme weather events on HIV outcomes: A global investigation
了解并减轻极端天气事件对艾滋病毒感染结果的影响:一项全球调查
- 批准号:
10762607 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Role of serum advanced glycation end-products in altering tendon properties with diabetes
血清晚期糖基化终末产物在改变糖尿病肌腱特性中的作用
- 批准号:
10737036 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别: